SE Health

sehc.com

SE Health (Saint Elizabeth Health Care) is a social enterprise applying knowledge, vision and drive to forever impact how people live and age at home, today and into the future. With Canadian roots and 110 years of expertise, the not-for-profit organization brings quality excellence and innovation to home care, seniors lifestyle and family caregiving. Through its team of 9,000 Leaders of Impact, SE Health delivers 20,000 care exchanges daily, totaling 50 million in the last decade alone.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMACEUTICAL COMPANIES RAISE HEALTH SERVICE SPONSORSHIP TO €58M

Dutch News BV | May 11, 2017

news image

Pharmaceutical companies spent €58.5m sponsoring doctors, patients organisations and healthcare providers last year, the Volkskrant said on Thursday....

Read More

THE AMAZON, BERKSHIRE HATHAWAY, JP MORGAN CHASE HEALTHCARE JOINT VENTURE NOW NAMED HAVEN

Biospace | March 07, 2019

news image

In January 2018, Berkshire Hathaway’s Warren Buffett, Amazon’s Jeff Bezos, and JP Morgan Chase’s Jamie Dimon announced they were creating a joint venture to slash healthcare costs and improve services. For more than a year, it had no name other than “ABC,” the first letters of each company’s name. Now, more than a year later, the endeavor has an official name, Haven. The three moguls formed the company with the idea of improving healthcare access and lowering ...

Read More

GROUND-BREAKING COLLABORATION TO OFFER NEW HEART DISEASE DRUG TO NHS PATIENTS

Pharmacy Business | January 14, 2020

news image

The government on Monday announced a collaboration with Novartis to launch a clinical trial for ‘yet to be approved’ drug inclisiran. The drug could benefit thousands of patients at risk of heart disease in coming years. The ground-breaking collaboration includes Novartis, NHS England and the National Institute for Health Research (NIHR) and Oxford University. The Department of Health and Social Care (DHSC) expects this to position the UK as a world-leading destination to develop cut...

Read More

CIVICA RX PARTNERS WITH THERMO FISHER SCIENTIFIC TO DEVELOP AND MANUFACTURE DRUGS WITH A HISTORY OF DRUG SHORTAGES

Business Wire Press Releases | January 16, 2020

news image

Today announced it has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway. By working with Thermo Fisher to develop Civica-owned Abbreviated New Drug Applications (ANDAs), Civica will secure the manufacture of certain essential medications, further mitigating the risk of drug shortages in the future. This partnership has an initial seven-year term and represents a key component of Civica’s man...

Read More
news image

PHARMACEUTICAL COMPANIES RAISE HEALTH SERVICE SPONSORSHIP TO €58M

Dutch News BV | May 11, 2017

Pharmaceutical companies spent €58.5m sponsoring doctors, patients organisations and healthcare providers last year, the Volkskrant said on Thursday....

Read More
news image

THE AMAZON, BERKSHIRE HATHAWAY, JP MORGAN CHASE HEALTHCARE JOINT VENTURE NOW NAMED HAVEN

Biospace | March 07, 2019

In January 2018, Berkshire Hathaway’s Warren Buffett, Amazon’s Jeff Bezos, and JP Morgan Chase’s Jamie Dimon announced they were creating a joint venture to slash healthcare costs and improve services. For more than a year, it had no name other than “ABC,” the first letters of each company’s name. Now, more than a year later, the endeavor has an official name, Haven. The three moguls formed the company with the idea of improving healthcare access and lowering ...

Read More
news image

GROUND-BREAKING COLLABORATION TO OFFER NEW HEART DISEASE DRUG TO NHS PATIENTS

Pharmacy Business | January 14, 2020

The government on Monday announced a collaboration with Novartis to launch a clinical trial for ‘yet to be approved’ drug inclisiran. The drug could benefit thousands of patients at risk of heart disease in coming years. The ground-breaking collaboration includes Novartis, NHS England and the National Institute for Health Research (NIHR) and Oxford University. The Department of Health and Social Care (DHSC) expects this to position the UK as a world-leading destination to develop cut...

Read More
news image

CIVICA RX PARTNERS WITH THERMO FISHER SCIENTIFIC TO DEVELOP AND MANUFACTURE DRUGS WITH A HISTORY OF DRUG SHORTAGES

Business Wire Press Releases | January 16, 2020

Today announced it has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway. By working with Thermo Fisher to develop Civica-owned Abbreviated New Drug Applications (ANDAs), Civica will secure the manufacture of certain essential medications, further mitigating the risk of drug shortages in the future. This partnership has an initial seven-year term and represents a key component of Civica’s man...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us